Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) is one of 296 public companies in the “Chemicals” industry, but how does it contrast to its peers? We will compare Bioceres Crop Solutions to similar businesses based on the strength of its risk, institutional ownership, earnings, analyst recommendations, valuation, profitability and dividends.
Earnings & Valuation
This table compares Bioceres Crop Solutions and its peers top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Bioceres Crop Solutions | $238.30 million | -$258.15 million | -0.06 |
| Bioceres Crop Solutions Competitors | $7.96 billion | $229.42 million | 20.56 |
Bioceres Crop Solutions’ peers have higher revenue and earnings than Bioceres Crop Solutions. Bioceres Crop Solutions is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Bioceres Crop Solutions and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bioceres Crop Solutions | -94.76% | -41.35% | -9.55% |
| Bioceres Crop Solutions Competitors | -54.07% | -0.31% | -1.28% |
Analyst Recommendations
This is a summary of recent recommendations and price targets for Bioceres Crop Solutions and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bioceres Crop Solutions | 1 | 1 | 0 | 0 | 1.50 |
| Bioceres Crop Solutions Competitors | 3271 | 12237 | 14147 | 520 | 2.39 |
Bioceres Crop Solutions currently has a consensus price target of $2.00, suggesting a potential upside of 759.48%. As a group, “Chemicals” companies have a potential upside of 6.73%. Given Bioceres Crop Solutions’ higher possible upside, analysts plainly believe Bioceres Crop Solutions is more favorable than its peers.
Institutional & Insider Ownership
17.7% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are owned by institutional investors. 2.3% of Bioceres Crop Solutions shares are owned by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Risk and Volatility
Bioceres Crop Solutions has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Bioceres Crop Solutions’ peers have a beta of 0.94, suggesting that their average stock price is 6% less volatile than the S&P 500.
Summary
Bioceres Crop Solutions peers beat Bioceres Crop Solutions on 11 of the 12 factors compared.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
